TransPharma Medical
Pioneering transdermal drug delivery to enhance therapeutic outcomes for osteoporosis and other peptide-based treatments.
General Information
Get notified when TransPharma Medical moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track TransPharma Medical
Get real-time alerts for funding, hiring, news, and 40+ signal types.
Start Tracking — FreeDiscover More
Biotechnology
About TransPharma Medical
Taxonomy: transdermal drug delivery, osteoporosis treatment, peptide-based treatments, pharmaceutical company, drug-product development, active transdermal technology, clinical trials, proprietary drug development, specialty pharmaceuticals, Phase 2B trials, Phase 1 trials, innovative drug delivery, collaboration with Eli Lilly, therapeutic outcomes, specialty pharmaceutical development
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series C | •••••• | 7 |
|
24 Jul 2006 |
| Series B | •••••• | 3 |
|
18 Jan 2003 |
| Series A | •••••• | - | 01 Jan 2001 |
TransPharma Medical Alternatives & Competitors
A fully-integrated specialty pharmaceutical company with industry-leading transdermal expertise
Pioneering advanced transdermal patches and oral films for enhanced efficacy and patient comfort.
Harnessing proprietary technologies to advance transdermal drug delivery for enhanced therapeutic ou...
FAQ About TransPharma Medical
Don't just browse. Track.
Signal Tracker monitors TransPharma Medical and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.